Kirby Institute, UNSW |Media release | Published on 04 Sep 2024 Over the last decade, HIV diagnoses in Australia have continued to follow a downward trend, according to new data released today by the Kirby Institute at UNSW Sydney. While there were 722 new HIV diagnoses reported nationally in 2023 – up from 553 in 2022 – the researchers still reported a lower number of annual cases compared to...
June 2024, eSafety Commissioner (Australia) ‘Tipping the balance: LGBTIQ+ teens’ experiences negotiating connection, self-expression and harm online’ is based on the experiences of 305 Australian young people aged 14 to 17, who identified as LGBTIQ+. This research explores the online experiences of LGBTIQ+ teens and how they negotiate connection, express themselves and deal with harm...
January 2024 Our Significant Dates Calendar covers the dates and milestones that help us raise awareness of the issues and topics we care about in sexual health and relationship wellbeing, and related areas. The resource has been updated for 2024. The calendar is a list of 2024 events including Sexual Health Week; Mental Health Week; World Autism Day; Aboriginal and Torres Strait Islander HIV...
ViiV Healthcare, July 2023 Join in the discussion with Dr Nneka Nwokolo on health issues faced by women living with HIV. Dr Nwokolo is Head of Global Patient Affairs at ViiV Healthcare and an honorary Consultant Physician in Sexual Health and HIV Medicine at Chelsea and Westminster Hospital in London where she continues to see patients in a combined general and menopause clinic. Date & time:...
Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV . These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...
van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus...